The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19

Thromb Res. 2021 Jun:202:14-16. doi: 10.1016/j.thromres.2021.02.031. Epub 2021 Mar 6.

Authors

Rodolfo Jiménez-Soto¹, Mercedes Aguilar-Soto², Carlos Andrés Rodríguez-Toledo², Antonio Camiro-Zúñiga², Roberta Demichelis³; ARMII Study Group

Affiliations

¹ Internal Medicine, ABC Medical Center, Mexico City, Mexico. Electronic address: jsrodo25@gmail.com.
² Internal Medicine, ABC Medical Center, Mexico City, Mexico.
³ Hematology, ABC Medical Center, Mexico City, Mexico.

Abstract

Unlabelled Image

Keywords: Anticoagulation; COVID-19; Enoxaparin; Thrombosis.

Publication types

Letter

MeSH terms

Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Blood Coagulation
COVID-19*
Enoxaparin / pharmacology
Humans
SARS-CoV-2

Substances

Anticoagulants
Enoxaparin